Form4insider filings, from the source

SEC Form 4 · accession 0001144204-18-035850

Kezar Life Sciences, Inc. · KZR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
Jun 25, 2018
Accepted (ET)
Jun 26, 2018 · 4:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001645666

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock, par value $0.001 per shareF1,F2,F4,F5Jun 25, 2018C290,924—A290,924ISee footnotes
Common Stock, par value $0.001 per shareF1,F3,F4,F5Jun 25, 2018C23,894—A23,894ISee footnotes

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series B Preferred Stock, par value $0.001 per shareF2,F4,F5,F1—Jun 25, 2018C290,924A——Common Stock290,9240I
Series B Preferred Stock, par value $0.001 per shareF3,F4,F5,F1—Jun 25, 2018C23,894A——Common Stock23,8940I

Explanation of responses